Topical Timolol for the Treatment of Benign Vascular Periocular Lesions

• Status: Withdrawn
• Trial end date: 2012-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this research is to find out if the use of topical timolol 0.5% solution applied twice daily will help to shrink rosacea lesions around the eye.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Loyola University
• Treatments: Timolol

Criteria

Inclusion Criteria:

• Presence of a benign vascular periocular lesion

Exclusion Criteria:

• Allergy to timolol or beta-blocker class of drugs

• Lesion characteristics concerning for atypia or malignancy including madarosis, ulceration, and recurrence after previous surgery.

• Intraocular Pressure less than 10 mm Hg